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Introduction: Evidence is present that the phospholipid composition of circulating cell-derived microparticles
(MP) affects coagulation in vivo, and that postprandial metabolic alterations may be associated with hyper-
coagulable state. Our objective was to investigate whether postprandial metabolic responses affect the phos-
pholipid composition of MP, and whether such changes are associated with coagulation activation.
Materials and Methods: Twelve healthy males were studied twice and randomly received two consecutive
meals or remained fasted. Blood was collected before and at 2, 4, 6 and 8 h following breakfast. Plasma con-
centrations of prothrombin-F1+2 and thrombin-antithrombin-complexes were measured. Numbers and cel-
lular origin of MP were determined by ﬂowcytometry. The phospholipid composition of MP was determined
by hpTLC. In vitro procoagulant activity of MP was studied by ﬁbrin generation.
Results: During the meal visit, plasma glucose, triglyceride and insulin levels increased, compared to baseline
and the fasting visit (all Pb0.05). Postprandially, the total numbers of MP increased in time compared to the
fasting visit (Pb0.05). Erythrocyte-derivedMP increased (6-fold) during themeal visit, but remained constant
on the fasting day (Pb0.001). On the meal versus fasting day circulating MP contained increased phosphati-
dylcholine (Pb0.05) and decreased sphingomyelin (Pb0.05) amounts. The amount of phosphatidylserine
did not change. Concentrations of plasma F1+2 and thrombin-antithrombin were similar on both days, as
was the ability of MP to generate ﬁbrin in vitro.
Conclusion: Although numbers, cellular origin and phospholipid composition of MP alter during exposure to
two consecutive meals in healthy subjects, this does not lead to changes in the coagulation activation in vivo.
© 2011 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
Clinical and epidemiological evidence indicates that postprandial
elevations of plasma glucose and triglyceride-rich lipoproteins are
related to the risk of atherothrombotic disease [1]. To which extent
postprandial coagulation activation contributes to this risk is still
under debate. Several investigators reported postprandial coagula-
tion activation in healthy subjects and in patients suffering from cardio-
vascular disease, as measured by increased plasma concentrations of
factor VIIa (FVIIa), prothrombin fragment F1+2 (F1+2) or thrombin-
antihrombin complexes (TAT)[2–11]. Explanations for the underlyingprothrombin fragment F1+2;
cles; BMI, body mass index;
ipoprotein cholesterol; LDL-C,
mance Thin Layer Chromatog-
curve.
edicine, Diabetes Center, VU
msterdam, The Netherlands.
en).
vier OA license.mechanism(s) of coagulation activation in the postprandial state, how-
ever, range from activation of factor VII (FVII) and XI (FXI) by triglycer-
ides to increased activity of plasminogen activator inhibitor (PAI). Of
interest, other investigators found that postprandial FVII activation
was not associated with increased concentrations of F1+2 and TAT
[12,13]. Similarly, there is no consensus among investigators whether
platelet activation occurs in the context of postprandial lipemia [14,15].
By exposing negatively charged phospholipids, mainly phosphati-
dylserine, but also by exposing tissue factor, cell-derived microparti-
cles (MP) can propagate and even initiate coagulation [16–18].
Therefore, MP have been associated with coagulation activation in
health and disease, and elevated numbers of circulating MP are re-
lated with an increased risk of thromboembolic events as well as
with disseminated intravascular coagulation [16–18]. Recently, we
demonstrated that the total number of MP in plasma from healthy
males is elevated following consecutive meals, suggesting that the
postprandial state induces the formation of MP [19]. At present, it
is unknown to which extent quantitative and qualitative character-
istics of MP are associated with coagulation in the postprandial
state. Therefore, we investigated whether the postprandial state
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pholipid composition of circulating MP, their procoagulant pheno-
type and the association with coagulation activation in vivo.
Materials and Methods
Subjects
Twelve healthy males, Caucasian, aged between 20–35 years, hav-
ing a body mass index (BMI) less than 27 kg/m2 and a blood pressure
b145/90 mmHg were included as previously described [19]. Current
smoking, the use of drugs (except for incidental analgesic agents)
and the presence of cardiovascular disease, hypertension, coagulation
disorders, diabetes mellitus, or 1st degree family history of aforemen-
tioned diseases were exclusion criteria. Subjects were initially studied
during a screening visit after having given written informed consent.
The local ethics committee approved the study and the investigation
conformed to the principles outlined in the Declaration of Helsinki.
Study design
Each participant was studied at 2 occasions, following an over-
night fast (from 8.00 PM the previous evening). Subjects had to re-
frain from heavy physical activities during 24 hours prior to each
visit. During the meal day, the participants received 2 consecutive,
isocaloric (900 kcal) test meals at time points t=0 (breakfast) and
4 hours (lunch). Blood samples were collected before and at 2, 4, 6
and 8 hours following the ﬁrst meal. During the fasting day, blood
samples were collected at similar times from 8.00 AM onwards and
the subjects were only allowed water at libitum. The order of the
visits was randomized and the time interval between the control
and meal visits was less than 4 weeks.
Test Meals
We used 2 standardized iso-caloric fat-rich mixed meals served as
breakfast (8.30 AM) and lunch (12.30 PM), instead of rather artiﬁcial
high-fat (ice-)cream shakes, to mimic a more real-life situation. Each
meal consisted of 50 g fat, of which 60% was saturated, 55 g carbohy-
drates and 30 g protein. The breakfast consisted of EggMcMufﬁn®
(McDonald's, afﬁliation Amsterdam-Sloten, The Netherlands), croissant
with butter and marmalade, 200 mL of milk, combined with 20 ml of
cream. The lunch consisted of Quarterpounder® (McDonald's, afﬁlia-
tion Amsterdam-Sloten, The Netherlands), croissant with butter, and
200 mL of milk. The participants were instructed to consume each
meal within 15 minutes.
Blood Sample Collection
To avoid coagulation, endothelial, and platelet activation arti-
facts, no in-dwelling canula was used and a new blood collecting
system (Microﬂex, size 1.0 mm - 19 G, Vygon, France) was used for
each blood collection. Venous blood was collected from the left
antecubital vein, the needle was placed at least 1 cm distal from the
previous insertion and stasis was carefully avoided, into 0.1 volume of
105 mmol/L trisodium citrate. Plasma was recovered after centrifuga-
tion (1550 g, 20 minutes, 20 °C) and aliquots of 250 μLwere snap frozen
in liquid nitrogen within 30 minutes after withdrawal and stored at
−80 °C until assay. All samples from one subject were analyzed in the
same series.
Biochemical measurements
Plasma glucose was measured by a hexokinase-based technique
(Roche diagnostics, Mannheim, Germany), HbA1c by HPLC. Insulin
was measured by a commercially available immunoradiometricassay (Biosource/Medgenix Diagnostics, Fleurus, Belgium). Plasma
total cholesterol, high-density lipoprotein cholesterol (HDL-C) and
triglycerides were determined by enzymatic methods (Modular,
Hitachi, Japan). Low-density lipoprotein cholesterol (LDL-C) was cal-
culated by the Friedewald formula. Non-esteriﬁed fatty acids (NEFA)
were assessed with an enzymatic colorimetric method (WAKO che-
micals, Neuss, Germany). F1+2 and TAT were determined by ELISA
(Dade Behring, Eschborn, Germany).
Reagents and Assays
Phospholipid standards were obtained from Larodan (Malmö,
Sweden): l-α-phosphatidylcholine, l-α-lyso-phosphatidylcholine,
sphingomyelin, l-α-phosphatidylserine, l-α-phosphatidylinositol,
l-α-phosphatidylethanolamine. The l-α-lyso- phosphatidylethanol-
amine standard was obtained from Sigma (St. Louis, MO). Chloroform
(analytical grade) and ethylacetate, acetone, methanol, ethanol,
dichloromethane, isopropanol, acetic acid (all HPLC grade) and
HPTLC plates (Cat. No. 1.05641; 20×10 cm, Silicagel 60 Å pore size,
particle size 5–17 μm, 0.2 mm layer thickness) were obtained from
Merck (Darmstadt, Germany). All other chemicals were of analytical
quality. Phycoerythrin (PE)-labelled anti-glycophorin A (JC159, IgG1)
and anti-CD61-PE (Y2/51, IgG1) were from Dako A/S (Glostrup,
Denmark), anti-CD4-PE (CLB-T4/2,6D10, IgG1), anti-CD66e-PE (CLB-
gran/10, IH4Fc, IgG1) from Sanquin (Amsterdam, The Netherlands),
anti-CD8-PE (SK1, IgG1), anti-CD14-PE (MØP9, IgG2b), anti-CD20-
PE (L27, IgG1), IgG1-PE (X40), IgG2b-PE (S2) and IgG1-peridinin
chlorophyll-a protein (PerCP; X40) from Becton Dickinson (San Jose,
CA), anti-CD62e-PE (1.2B6, IgG1) from Serotec Ltd (Oxford, England),
anti-CD66b-PE (80H3, IgG1 ) and ﬂuoresceinisothiocyanate (FITC)-
labeled anti-CD66b (0531) from Coulter/Immunotech (Marseille,
France), and allophycocyanin (APC)-labelled annexin V-APC from Phar-
mingen (San Jose, CA), anti-CD106-FITC (B44498) from Calbiochem-
Novabiochem Corporation (San Diego, CA) and anti-CD144-FITC (BMS
158FI) from Bender MedSystems Diagnostics GmbH (Vienna, Austria).
Isolation of MP
Per time point, two 250 μl aliquots were thawed on melting ice,
and centrifuged for 30 minutes at 17,590 g and 20 °C. The supernatant
(225 μl) was removed and 225 μl phosphate-buffered saline (PBS)
containing 0.32% trisodium citrate (154 mmol/L NaCl, 1.4 mmol/L
phosphate and 10.9 mmol/L trisodiumcitrate, pH 7.4) was added.
The MP were resuspended and again centrifuged for 30 minutes at
17,590 g and 20 °C. For ﬂowcytometry, 225 μl supernatant was re-
moved. Subsequently the MP were resuspended and diluted 4-fold
with PBS/citrate buffer, of which 5 μl was used per incubation. For
Bligh & Dyer extraction, the supernatant (225 μl) was removed and
the pellet was washed once more. Finally, 225 μl supernatant was re-
moved and the MP were resuspended in the remaining 25 μl.
Flowcytometric analysis of MP
The samples were analyzed in a FACScan ﬂowcytometer with Cell-
Quest software (Becton Dickinson, San Jose, CA). Forward scatter
(FSC) and sideward scatter (SSC) were set at logarithmic gain. To dis-
tinguish MP from events due to noise, MP were identiﬁed not only on
FCS and SSC characteristics, but also by binding of annexin V and a
MoAb directed against a celltype-speciﬁc antigen. To identify annexin
V-positive MP, a threshold was placed in a MP sample prepared in the
presence of annexin V without calcium to correct for autoﬂuores-
cence. To identify MP that bind cell type-speciﬁc MoAbs, the MP
were incubated with identical concentrations of isotype-matched
control antibodies to set the threshold. FITC-ﬂuorescence was mea-
sured in the FL-1 channel and PE-ﬂuorescence in the FL-2 channel.
Table 1
Baseline and fasting characteristics of the study population.
Healthy Males (n=12)
Age, yrs 26.0±0.9
BMI, kg/m2 23.9±0.4
Waist, cm 87.6±1.3
Systolic blood pressure, mmHg 116±2
Diastolic blood pressure, mmHg 72±2
HbA1c, % 5.2±0.1
Glucose, mmol/L 4.9±0.1
Insulin, pmol/L 34±3
Total-cholesterol, mmol/L 4.0±0.2
HDL-C, mmol/L 1.36±0.1
LDL-C, mmol/L 2.3±0.2
Triglycerides, mmol/L 0.8±0.1
Values are mean±SE. BMI indicates body mass index; HDL-C, HDL-cholesterol; LDL-C,
LDL-cholesterol.
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phosphate and 2.5 mmol/L CaCl2, pH 7.4), 5 μl annexin V-PE and 5 μl
FITC-labeled cell-speciﬁc MoAbs or isotype-matched control antibody
(IgG1-FITC) were added. MP (5 μl) were added, and the mixtures
were incubated in the dark for 15 min at room temperature. For the
CD66e-PE analysis an IgG1-PE control antibody was used. Subse-
quently, 900 μl PBS/calcium buffer was added to stop the labeling.
All samples were analyzed for 1 minute during which the ﬂowcyt-
ometer analyzed about 150 μl of the MP suspension. From the num-
ber of events (Nx) in the upper right (marker and annexin V-
positive) quadrant of the ﬂowcytometric analysis (FL-1 versus FL-2
corrected for isotype control and autoﬂuorescence), the number
of MP/L plasma was calculated: Number/L=Nx[100/5]×[950/60]×
[106/250], in which 5 (μL) is the volume of MP suspension, 100 is
the total volume of washed MP suspension, 950 is the total volume
in the tube before analysis, 60 is the sample volume analyzed, 106 is
the number of μL/L, and 250 is the original volume of plasma.
1.9. Phospholipid extraction
Phospholipids were extracted according to Bligh & Dyer [20,21].
To improve the recovery for phosphatidylserine and phosphatidylino-
sitol, the water phase was replaced by acetic acid (0.5%).
For each time point the remaining 25 μl of the two 250 μl aliquots
were pooled. To these 50 μl samples, 3 ml methanol:chloroform (2:1)
was added. The samples were thoroughly mixed for 30 s and 750 μl
0.5% acetic acid was added. Again the samples were mixed for 30 s.
Then, chloroform (1 ml) and 0.5% acetic acid (800 μl) were added.
After each addition, the samples were mixed for 30 s. Subsequently
the samples were centrifuged for 10 minutes at 1560 g (20 °C). The
chloroform fraction (at the bottom) was isolated, and the aqueous
fraction was washed twice with chloroform (1 mL). The three chloro-
form fractions were pooled and dried under nitrogen at 40 °C. The
samples were stored overnight in−20 °C, and redissolved in methanol:
chloroform (2:1) to be applied to hpTLC plates.
1.10. High Performance Thin Layer Chromatography (hpTLC)
To analyze cholesterol and phospholipid contents of the samples,
separate hpTLC plates were used, because the developing solvent
mixtures differ as previously described [21]. All hpTLC plates were
prerun (full height) with methanol:ethylacetate (6:4) in a Camag
horizontal developing chamber (Merck) to remove impurities. The
plates were activated for 10 minutes at 130 °C. The ﬁrst plate was
used for phospholipids analysis, whereas the second plate was used
for cholesterol analysis.
The identiﬁcation of phospholipids species was based upon a stan-
dard mixture of commercial phospholipid standards that was applied
to each hpTLC plate. The density of these spots was analyzed by photo-
densitometric scanning by a GS-800 Calibrated Imaging Densitometer
(Bio-Rad; Veenendaal, The Netherlands), quantiﬁed using Quantity
One software version 4.2.2 (Bio-Rad; Veenendaal, The Netherlands)
and expressed as arbitrary units.
Since plasma contains (phospho-)lipids and cholesterol, especially
in the postprandial state, and the (washed) MP fraction still contains
1% plasma (ﬁnal concentration), the lipid composition of MP was
corrected for this confounder. Therefore, 25 μl of supernatant from
the ﬁrst washing step was taken and 225 μl of PBS containing
0.32% trisodiumcitrate (pH 7.4) added. These samples were also
washed twice, extracted and analyzed, exactly as described for the
MP preparation.
1.11. Fibrin generation test (FGT)
The ability of MP to generate ﬁbrin was measured directly in plas-
ma of the participants in the absence or presence of anti-human(coagulation) factor VII, anti-human factor XI or anti-human factor
XII (all provided by Sanquin, Amsterdam, The Netherlands) as previ-
ously described [22]. After pre-incubation for 5 minutes at 37 °C, clot-
ting of plasma was initiated by addition of CaCl2. Fibrin formation
was determined by measuring the optical density (λ=405 nm) in
duplicate on a spectrophotometer (SPECTRAmax microplate reader;
Molecular Devices Corp., Sunnyvale, CA) at 37 °C.
Statistical Analysis
Based on our previous ﬁndings in detecting phospholipid changes
in platelet-derived MP after stimulating with different platelet ago-
nists, we performed a formal sample size calculation [21]. In order
to detect a similar change (over 20%) in phosphatidylcholine content
with a power of 0.8 and conﬁdence level of 0.95, at least 10 subjects
needed to be studied. Based on these data and taken into account
this calculation is based on solely platelet-derived MPs, we expected
that a number of 12 subjects in this study would yield meaningful re-
sults. Continuous variables are expressed as mean±SE, unless other-
wise stated. To estimate the overall metabolic responses and the
changes in MP during both visits, area under the curve (AUC) of
these parameters plotted against time were calculated. Differences
between time points on both days were calculated using ANOVA
and the P-values were corrected by the method of Bonferroni. Non-
parametrical tests were performed for non-normally distributed
data. Correlations were performed using the Spearman's test. A
Pb0.05 was considered statistically signiﬁcant. Data were analyzed
with SPSS for Windows, release 15.0.
Results
Postprandial metabolic changes
The clinical and baseline laboratory characteristics of the partici-
pants are depicted in Table 1. The baseline concentrations of
all parameters did not differ between the two study days. During the
meal visit, plasma glucose, triglyceride and insulin concentrations
rose signiﬁcantly, especially after the second meal, albeit all within
the normal range, as compared to baseline and the fasting visit (both
Pb0.05, Pb0.001, Pb0.001, respectively; Fig. 1). During the fasting
visit, plasma concentrations of NEFA rose signiﬁcantly from 0.29±0.1
to 0.74±0.1 mmol/L (Pb0.001 versus baseline and meals day).
Postprandial changes in circulating MP
The total numbers of MP, of which the largest fraction is platelet-
derived (88-98%), increased during the meal visit compared to the
Fig. 1. Plasma concentrations of glucose, triglycerides, insulin and NEFA during the meal (solid circles) and fasting days (open circles) in healthy males. Meal intake is indicated by
M. Bars (black, meals; white, fasting) in the insets represent respective AUC values. The P value is given for AUC difference. Data are mean±SE.
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derived MP increased to more than 6-fold after consumption of
bothmeals (Pb0.001, versus baseline and fasting day), and remained
unaffected during the fasting day. Finally, monocyte-derived MP
concentrations, constituting only 0.3% of the total numbers of circu-
lating MP, slightly increased during the meal visit (P=0.07 versus
fasting). MP from lymphocytes, granulocytes, and endothelial cells
were not detectable. The numbers of erythrocyte-derived MP corre-
lated signiﬁcantly with the corresponding insulin concentrations
measured on both days (r=0.65, Pb0.001).Postprandial changes in the phospholipid composition of circulating MP
Table 2 summarizes the overall phospholipid compositions of MP
during the meal (+) and fasting (−) day, expressed as percentage
of total phospholipid (mol/mol) after correction for the amount of
phospholipids in MP-free plasma (see Methods). Compared to the
fasting day, the relative % of phosphatidylcholine increased, whereas
concurrently sphingomyelin decreased. Furthermore, the amount of
phosphatidylinositol tended to increase following the ﬁrst meal, al-
though not signiﬁcant. The phospholipids phosphatidylserine, phos-
phatidylinositol and phosphatidylethanolamine were not detectable
in plasma that had been depleted from MP.
The cholesterol : phospholipid ratio of MP during the meals day
did not change signiﬁcantly. During the fasting day, however, the
cholesterol : phospholipid ratio increased signiﬁcantly from 0.34±
0.1 to 0.49±0.1 (Pb0.05; Fig. 3).Postprandial coagulation in vivo and in vitro
There were no signiﬁcant differences between the meal and fast-
ing day for both F1+2 and TAT concentrations (Fig. 4). Furthermore,
Fig. 5 shows the results of the ﬁbrin generation test on MP-containing
plasma performed at baseline and at time point t=6 hours (i.e.
6 hours after breakfast and 2 hours after lunch; these time intervals
were chosen since the metabolic changes were maximally different
from baseline). There were no signiﬁcant differences between the
two days in the ability of MP to trigger ﬁbrin formation in plasma in
the absence or presence of anti-human factor VII, factor XI or factor
XII.
Discussion
The present study demonstrates that not only the numbers and
cellular origin but also the phospholipid composition of circulating
cell-derived MP alters after consumption of two consecutive high-
fat mixed meals in healthy males. These alterations, however,
do not lead to enhanced coagulation activation in vitro and in vivo,
suggesting that these relatively minor changes in circulating MP are
insufﬁcient to cause a procoagulant state and that, under these phys-
iological conditions, MP do not affect coagulation.
Surprisingly, in the postprandial state, the numbers of eryth-
rocyte-derived MP markedly increased and these numbers were
strongly associated with insulin concentrations. Since insulin induces
a Ca2+-dependent hyperpolarization of erythrocyte membranes,
we hypothesize that this may be an inducer for the shedding of MP
Fig. 2. The course of total MP, platelet-derived MP, erythrocyte-derived MP and monocyte-derived MP numbers/L during the meal (solid circles) and fasting (open circles) days
in healthy males. Meal intake is indicated by M. Bars (black, meals; white, fasting) in the insets represent respective AUC values. The P value is given for AUC difference. Data
are mean±SE.
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we demonstrated that erythrocyte-derived MP are associated with
factor XI-dependent coagulation in sickle cell disease, but we couldTable 2
Phospholipid composition of MP during postprandial or fasting state.
Phospholipids Meals Time points (hours)
0 2 4 6 8
L-PC + 1.3±0.8 0.9±0.8 1.0±0.8 1.3±0.8 1.3±0.8
- 1.2±1.0 1.2±1.2 1.2±1.2 1.1±1.3 1.6±0.9
SM⁎ + 27±9.4 21±3.6# 23±5.5 22±4.5 22±4.7
- 24±5.8 23±6.3 25±5.0 25±4.7 25±5.5
PC⁎ + 46±6.8 47±7.8 46±8.5 49±10# 48±13
- 42±12 43±11 42±11 43±9.2 41±11
PS + 8.1±6.6 12±7.5 9.2±7.3 8.2±7.2 9.1±6.7
- 13±12 13±11 11±7.5 11±8.4 12±12
PI + 6.1±3.8 6.4±3.6 6.9±3.6 6.2±4.1 6.6±4.9
- 5.7±4.0 6.9±3.8 8.4±7.3 6.6±3.3 6.7±3.1
PE + 11±5.1 13±2.8 14±4.5 13±5.4 13±5.6
- 13±6.5 12±5.0 13±8.3 14±5.0 13±3.9
Data expressed as % of total phospholipid (mol/mol)±SE. *Pb0.05 (area under the
curve), #Pb0.05 (individual time points). L-PC indicates lyso-phosphatidylcholine; SM,
sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol;
PE, phosphatidylethanolamine.not conﬁrm this association in the present study. A possible explana-
tion is that the changes in the phospholipid composition, especially
the presence of oxidized and nonoxidized phospholipids, may differ-
entially affect coagulation [26].
In healthy individuals, cell-derivedMP originate predominantly from
platelets and contain mostly phosphatidylcholine and sphingomyelin,Fig. 3. The cholesterol : phospholipid (PL) ratio of MP during the meal (solid circles)
and fasting (open circles) days in healthy males. Meal intake is indicated by M. Data
are mean±SE.
Fig. 4. Plasma concentrations of F1+2 and TAT during the meal (solid circles) and fasting days (open circles) in healthy males. Meal intake is indicated by M. Bars (black, meals;
white, fasting) in the insets represent respective AUC values. The P value is given for AUC difference. Data are mean±SE.
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ine, and phosphatidylinositol, andminute quantities of the lysophospho-
lipids lyso-phosphatidylcholine, lyso-phosphatidylethanolamine and
lyso-phosphatidylserine. We showed that following two consecutive
meals the relative amount of phosphatidylcholine increases, whereas
concurrently sphingomyelin decreases in MP, compared to a fasting
day. These ﬁndings conﬁrm earlier studies showing that changes in the
phospholipid composition of MP vary between cell types and depend
on the activation status of the parental cell [21,27,28], e.g. platelet-
derived MP originating from collagen-activated platelets contained
less phosphatidylcholine and more sphingomyelin, phosphatidyletha-
nolamine and phosphatidylserine than non-stimulated platelets [27].
One of the important ﬁndings of the present study is that the
total amount of phosphatidylserine present in MP fractions remained
unaffected by fasting or meals in healthy subjects. Since phosphati-
dylserine exposed by MP or cells is believed to support the binding
of (activated) coagulation factors and thus the formation of tenase
and prothrombinase complexes, our present results may explain
why we found neither differences in coagulation activation in vivo
nor as coagulation activation potency in vitro.
In the present study, the phospholipid composition of in vivo MP
was corrected for the plasma background. We found this correction
to be essential, since both MP and MP-depleted plasma containedFig. 5. Fibrin generation tests (FGT) at baseline (t=0 hours) and at t=6 hours during
the meal (black bars) and fasting (white bars) days. Data are mean±SE.substantial quantities of phosphatidylcholine and sphingomyelin
[29]. In contrast, the quantities of phosphatidylserine, phosphatidyli-
nositol and phosphatidylethanolamine were below the detection
limit of our assay in MP-depleted plasma, whereas phosphatidylser-
ine, phosphatidylinositol as well as phosphatidylethanolamine
were clearly detectable in the corresponding fractions of MP. This
ﬁnding implicates that determination of the concentrations of
phosphatidylserine-exposing microparticles or their coagulant proper-
ties by capturing the MP from plasma by using ELISA plates coated
with annexin V may be a suitable tool for MP detection and possibly
quantiﬁcation ex vivo.
The observed increase in the cholesterol : phospholipid ratio of
circulating MP during a prolonged episode of fasting and its associa-
tion with plasma NEFA concentrations may be of interest. During
the fasting day, the concentrations of NEFA in our healthy population
increased almost 3-fold due to unsuppressed lipolysis, reaching levels
that are found in fasting patients with type 2 diabetes [30]. Previous-
ly, it was shown that the amount of cholesterol in membranes of
erythrocytes and leukocytes is associated with plasma fatty acids in
patients with type 2 diabetes [31]. Furthermore, we demonstrated
previously that MP released upon platelet activation have an in-
creased cholesterol content [21]. It has been shown in several studies
that growing cells in media with an altered balance of speciﬁc lipids,
particularly oligo-unsaturated fatty acids and sterols such as choles-
terol, affect the lipid composition of the plasma membrane [32,33].
Since cholesterol plays several structural and metabolic roles, partic-
ularly in membranes, cells may shed MP to cope with acute lipid
changes in plasma to retain their membrane qualities.
In conclusion, the numbers, cellular origin and phospholipid com-
position of cell-derived MP is altered upon consumption of two con-
secutive high-fat mixed meals in healthy males. However, these
alterations do not seem to affect the ability of circulating MP to acti-
vate coagulation, both in vivo and in vitro. We therefore hypothesize
that the suggested differences in (phospho-)lipid composition of cell-
derived MP on fasting and meal days reﬂect the ability to maintain
membrane homeostasis, rather than to modify coagulation.Conﬂict of interest statement
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